Total Funding
69
52
Total FundingSeries A raised
Growth Score 69 in past quarter
-4 pts
Heat Score 52 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
41144
Vernal Biosciences specializes in high-purity mRNA for research and clinical use.
- Jim Petrilla: CEO & Board DirectorPast Role: BioAgilytix Labs, Founder, President & CEO
About the Company
Vernal Biosciences specializes in high-purity mRNA for research and clinical use. Its platform processes and analytical methods will remove the guesswork and lengthy development cycles inherent to many manufacturing processes in the advanced therapeutics field. Its high-purity supply and services provide the flexibility to perform proper drug
discovery and development without risking the buildout of costly teams and facilities.
